Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1994 1
1997 1
2001 1
2002 1
2007 1
2008 1
2009 4
2010 3
2011 6
2012 7
2013 12
2014 11
2015 8
2016 13
2017 15
2018 7
2019 7
2020 18
2021 19
2022 8
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
Fakhouri F, Fila M, Hummel A, Ribes D, Sellier-Leclerc AL, Ville S, Pouteil-Noble C, Coindre JP, Le Quintrec M, Rondeau E, Boyer O, Provôt F, Djeddi D, Hanf W, Delmas Y, Louillet F, Lahoche A, Favre G, Châtelet V, Launay EA, Presne C, Zaloszyc A, Caillard S, Bally S, Raimbourg Q, Tricot L, Mousson C, Le Thuaut A, Loirat C, Frémeaux-Bacchi V. Fakhouri F, et al. Among authors: launay ea. Blood. 2021 May 6;137(18):2438-2449. doi: 10.1182/blood.2020009280. Blood. 2021. PMID: 33270832 Free article. Clinical Trial.
Antibio-gouvernance en néonatalogie.
Launay E, Gras-Le Guen C, Caillon J, Flamant C, Navas D, Ovetchkine P. Launay E, et al. Arch Pediatr. 2017 Dec;24 Suppl 3:S9-S13. doi: 10.1016/S0929-693X(18)30038-1. Arch Pediatr. 2017. PMID: 29433696 French.
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
Garnier A, Brochard K, Kwon T, Sellier-Leclerc AL, Lahoche A, Launay EA, Nobili F, Caillez M, Taque S, Harambat J, Michel-Bourdat G, Guigonis V, Fila M, Cloarec S, Djamal-Dine D, de Parscaux L, Allard L, Salomon R, Ulinski T, Frémeaux-Bacchi V, Morin C, Olivier-Abbal P, Colineaux H, Auriol F, Arnaud C, Kieffer I, Brusq C. Garnier A, et al. Among authors: launay ea. J Am Soc Nephrol. 2023 Sep 1;34(9):1561-1573. doi: 10.1681/ASN.0000000000000182. Epub 2023 Jun 12. J Am Soc Nephrol. 2023. PMID: 37303085 Clinical Trial.
Optimal population-specific HLA imputation with dimension reduction.
Douillard V, Dos Santos Brito Silva N, Bourguiba-Hachemi S, Naslavsky MS, Scliar MO, Duarte YAO, Zatz M, Passos-Bueno MR, Limou S, Gourraud PA, Launay É, Castelli EC, Vince N; SNP-HLA Reference Consortium (SHLARC). Douillard V, et al. Among authors: launay e. HLA. 2023 Nov 11. doi: 10.1111/tan.15282. Online ahead of print. HLA. 2023. PMID: 37950640
Surgical and medical antibiotic prophylaxis.
Haas H, Launay E, Minodier P, Cohen R, Gras-Le Guen C. Haas H, et al. Among authors: launay e. Arch Pediatr. 2017 Dec;24(12S):S46-S51. doi: 10.1016/S0929-693X(17)30519-5. Arch Pediatr. 2017. PMID: 29290235
Prenatal phenotype of 22q11 micro-duplications: A systematic review and report on 12 new cases.
Mary L, Lavillaureix A, Perrot A, Loget P, Launay E, Leborgne AS, Demurger F, Fradin M, Le Bouar G, Quélin C, Dubourg C, Pasquier L, Odent S, Belaud-Rotureau MA, Jaillard S. Mary L, et al. Among authors: launay e. Eur J Med Genet. 2022 Feb;65(2):104422. doi: 10.1016/j.ejmg.2022.104422. Epub 2022 Jan 10. Eur J Med Genet. 2022. PMID: 35026468 Free article. Review.
138 results